• Western blot analysis of extracts of various cell lines, using MRPL2 antibody (STJ116615) at 1:1000 dilution. Secondary antibody: HRP Goat Anti-rabbit IgG (H+L) at 1:10000 dilution. Lysates/proteins: 25ug per lane. Blocking buffer: 3% nonfat dry milk in TBST. Detection: ECL Basic Kit. Exposure time: 90s.

Anti-MRPL2 antibody (1-305) (STJ116615)

SKU:
STJ116615

Shipping:
Free Shipping
Current Stock:
Host: Rabbit
Applications: WB
Reactivity: Human/Mouse
Note: STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS.
Short Description: Rabbit polyclonal antibody anti-MRPL2 (1-305) is suitable for use in Western Blot research applications.
Clonality: Polyclonal
Conjugation: Unconjugated
Isotype: IgG
Formulation: PBS with 0.01% Thimerosal, 50% Glycerol, pH7.3.
Purification: Affinity purification
Dilution Range: WB 1:500-1:2000
Storage Instruction: Store at-20°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles.
Gene Symbol: MRPL2
Gene ID: 51069
Uniprot ID: RM02_HUMAN
Immunogen Region: 1-305
Immunogen: Recombinant fusion protein containing a sequence corresponding to amino acids 1-305 of human MRPL2 (NP_057034.2).
Immunogen Sequence: MALCALTRALRSLNLAPPTV AAPAPSLFPAAQMMNNGLLQ QPSALMLLPCRPVLTSVALN ANFVSWKSRTKYTITPVKMR KSGGRDHTGRIRVHGIGGGH KQRYRMIDFLRFRPEETKSG PFEEKVIQVRYDPCRSADIA LVAGGSRKRWIIATENMQAG DTILNSNHIGRMAVAAREGD AHPLGALPVGTLINNVESEP GRGAQYIRAAGTCGVLLRKV NGTAIIQLPSKRQMQVLET
Protein Name Large Ribosomal Subunit Protein Ul2m
39s Ribosomal Protein L2 - Mitochondrial
L2mt
Mrp-L2
Database Links Reactome: R-HSA-5368286
Reactome: R-HSA-5389840
Reactome: R-HSA-5419276
Cellular Localisation Mitochondrion
Alternative Antibody Names Anti-Large Ribosomal Subunit Protein Ul2m antibody
Anti-39s Ribosomal Protein L2 - Mitochondrial antibody
Anti-L2mt antibody
Anti-Mrp-L2 antibody
Anti-MRPL2 antibody
Anti-CGI-22 antibody

Information sourced from Uniprot.org

12 months for antibodies. 6 months for ELISA Kits. Please see website T&Cs for further guidance